It’s been said before and it’s true: a healthy scalp is key to healthy hair. But for those dealing with pesky and sometimes painful scalp conditions like seborrheic dermatitis, that can be easier said ...

Seborrheic dermatitis is a chronic, inflammatory skin disease that affects more than 10 million people in the U.S. Survey found that, among adults with seborrheic dermatitis who use treatments, only ...

(RTTNews) - Arcutis Canada announced that Health Canada has approved ZORYVE for the treatment of seborrheic dermatitis in patients 9 years of age and older. The Health Canada approval is based on ...

New York — Seborrheic dermatitis (SD) is a common and shared disorder across populations, but it is the third most common dermatologic complaint that Black individuals bring to the dermatologist and ...

Phase 3 development to consist of single pivotal trial Previously reported data demonstrated that roflumilast foam provided statistically significant improvement and a favorable safety and ...

Please provide your email address to receive an email when new articles are posted on . 73.8% of roflumilast-treated patients achieved the primary endpoint compared with 40.9% of the vehicle group.

WESTLAKE VILLAGE, Calif., Dec. 15, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (ARQT), an early commercial-stage company focused on developing meaningful innovations in immuno-dermatology, ...

NDA supported by positive efficacy and safety data from the Phase 2 and pivotal Phase 3 trials of roflumilast foam If approved, roflumilast foam would be the first topical drug for seborrheic ...

Q I have dandruff, and my doctor says it’s from seborrheic dermatitis. Can you explain what that is? I’ve been using the special shampoo I was given, and it helps. When I stop using it, though, the ...